Clinical Operations, • 9/19/25 Optimizing CRO and Vendor Selection - Examples from the Field Previous Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Next Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Case Studies in Rare Disease Commercialization: Lessons Learned How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials
Clinical Operations, • 9/19/25 Optimizing CRO and Vendor Selection - Examples from the Field Previous Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials Next Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Case Studies in Rare Disease Commercialization: Lessons Learned How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials
